9.58
price down icon3.33%   -0.33
after-market Handel nachbörslich: 9.59 0.010 +0.10%
loading

Finanzdaten der Biohaven Ltd-Aktie (BHVN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Research and Development
13.62%
121.94
141.17 184.37 187.58 157.61
Costs And Expenses
15.73%
142.73
169.38 211.70 221.56 178.17
Operating Income/Loss
15.73%
-142.73
-169.38 -211.70 -221.56 -178.17
Nonoperating Income/Loss
35.68%
-2.47
-3.84 13.81 0.493 17.80
Income/Loss From Continuing Operations Before Tax
16.17%
-145.20
-173.22 -197.89 -221.07 -160.36
Income Tax Expense/Benefit
58.82%
0.351
0.221 0.261 0.609 -0.059
Income/Loss From Continuing Operations After Tax
16.08%
-145.56
-173.44 -198.15 -221.68 -160.30
Net Income/Loss
16.08%
-145.56
-173.44 -198.15 -221.68 -160.30
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
96.00%
4.2336
105.82 102.37 101.94 94.37
Diluted Average Shares
96.00%
4.2336
105.82 102.37 101.94 94.37
Basic Earnings Per Share
31.71%
-1.12
-1.64 -1.94 -2.17 -1.70
Diluted Earnings Per Share
31.71%
-1.12
-1.64 -1.94 -2.17 -1.70
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):